number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide GLP-1 Market Size, Share Tirzepatide for Weight Loss |
Description
Both medications were originally approved for diabetes treatment and provide excellent blood sugar control along with weight loss
Liraglutide (Victoza, Saxenda) Approved for obesity at higher doses, typically results in 57% weight loss
Survodutide: GLP-1 and Glucagon Receptor Activator Survodutide is a dual agonist targeting both GLP-1 and glucagon receptors, enhancing its weight loss effects
Clinical trials for pharmaceutical-grade oral tirzepatide are ongoing
It might mean switching formats
Our peptide cost calculator can help you estimate treatment costs across different dosing schedules
